Source: Annual Congress 2012 - Basic and translational studies in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S.S. Sohal, A. Soltani, D. Reid, C. Ward, S. Weston, H.K. Muller, R. Wood-Baker, E.H. Walters (Hobart, Brisbane, Australia; Newcastle-upon-Tyne, United Kingdom). Inhaled corticosteroids (ICS) attenuates epithelial mesenchymal transition (EMT) in COPD: A key to understanding long term benefits?. Eur Respir J 2012; 40: Suppl. 56, 1439

Member's Comments

No comment yet.

Related content which might interest you: Inhaled corticosteroids attenuate epithelial mesenchymal transition: implications for COPD and lung cancer prophylaxis Source: Eur Respir J, 54 (1) 1900778; 10.1183/13993003.00778-2019 Year: 2019 Synergistic effect of human tubal mesenchymal stem cell (htMSCs) and low level laser (LLL) therapy significantly reduces experimental COPD in mice Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Cancer-protective effects of inhaled corticosteroids in COPD are likely related to modification of epithelial activation Source: Eur Respir J, 54 (3) 1901088; 10.1183/13993003.01088-2019 Year: 2019 Inhaled corticosteroids reduce senescence in endothelial progenitor cells from COPD patients Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases Year: 2021 Effect of switching from high-dose inhaled corticosteroid (ICS) to low-dose ICS plus an inhaled long-acting β2-agonist on asthma control, airway inflammation and remodeling, and gene expression in airway epithelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 35s Year: 2003 TGFβ-induced epithelial to mesenchymal transition (EMT) as a model of COPD Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair Year: 2016 Epithelial mesenchymal transition (EMT) related changes in small airways of smokers and patients with COPD Source: Virtual Congress 2021 – Pathogenic progress in airway diseases Year: 2021 Both intranasal and intraperitoneal administration of human tubal mesenchymal stem cells (htMSC) ameliorates experimental COPD model Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Platelet activating factor receptor (PAFr) expression is increased in airways of COPD patients but is not attenuated by inhaled corticosteroid (ICS) Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Treatment with inhaled corticosteroids (ICS) and long acting b2-agonists (LABA) combination in patients with COPD: Possible way of optimization Source: Annual Congress 2011 - Airways disease comorbidities and general aspects Year: 2011 COPD: Inhaled corticosteroid (ICS) and long-acting beta2-agonist (LABA) combination and oxygen saturation (OS) in patients (pts) with different plasma surfactant protein D (SP-D) level Source: International Congress 2015 – COPD: notable points Year: 2015 Reducing the dose of inhaled corticosteroids (ICS) under therapy with montelukast in stable asthma: effects on lung function and inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 261s Year: 2001 Corticosteroids and beta2-agonists regulate pathologic homeostasis of hyaluronic acid in human airway smooth muscle cells from patients with asthma and COPD. Therapeutic relevance Source: Annual Congress 2010 - Airway cells as targets for anti-inflammatory drugs Year: 2010 Treatment with inhaled corticosteroids (ICS) in patients with COPD: possible way of optimisation Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 E-cadherin (CDH-1) polymorphisms associate with airway remodeling, inflammation and FEV1 decline in asthma patients using inhaled corticosteroids (ICS) Source: Annual Congress 2010 - The impact of genes and environment on obstructive airway diseases Year: 2010 Inhaled corticosteroids and increased microbial load in COPD: potential role of epithelial adhesion molecules Source: Eur Respir J, 51 (2) 1702257; 10.1183/13993003.02257-2017 Year: 2018 Epithelial mesenchymal transition (EMT) in small and large airways of smokers; and relation to airflow obstruction Source: International Congress 2015 – Airway remodelling: recent developments Year: 2015 Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma Source: Eur Respir J 2006; 27: 172-187 Year: 2006 Inhaled corticosteroids and growth of airway function in asthmatic children Source: Eur Respir J 2004; 23: 861-868 Year: 2004 Inhibition of phosphodiesterase 4B enhances glucocorticoid-dependent gene transcription in human airway epithelial cells: Implications for the treatment of COPD Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013